Davita Healthcare Partners Stock News

Should investors be paying more attention to these health care stocks?

DaVita's (DVA) work with transplant providers and kidney doctors is likely to slow CKD progression and bolster access to home dialysis and kidney transplantation.

DaVita's (DVA) work with transplant providers and kidney doctors is likely to slow CKD progression and bolster access to home dialysis and kidney transplantation.

DaVita (DVA) acquires MedSleuth which will help simplify the kidney transplant process and provide patients greater access to transplantation.

With stocks offering dialysis services, including DaVita (DVA), facing several issues, it would be prudent to invest in medical care and services stocks like DGX, AMN and CODX instead for 2022.

With stocks offering dialysis services, including DaVita (DVA), facing several issues, it would be prudent to invest in medical care and services stocks like DGX, AMN and CODX instead for 2022.

DVA, CSII, BYND, AVYA, and GFF have been added to the Zacks Rank #5 (Strong Sell) List on December 28, 2021.

DVA, CSII, BYND, AVYA, and GFF have been added to the Zacks Rank #5 (Strong Sell) List on December 28, 2021.

Janney Montgomery Scott LLC reduced its stake in DaVita Inc. (NYSE:DVA) by 31.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,588 shares of the companys stock after selling 8,255 shares during the period. Janney Montgomery Scott [] The post Janney Montgomery Scott LLC Sells 8,255 Shares of DaVita Inc. (NYSE:DVA) appeared first on ETF Daily News .

Shares of DaVita Inc. (NYSE:DVA) have been given an average rating of Hold by the nine analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating on the company. The average twelve-month []

Analysts predict that DaVita Inc. (NYSE:DVA) will announce $2.91 billion in sales for the current quarter, Zacks reports. Four analysts have made estimates for DaVitas earnings. The lowest sales estimate is $2.87 billion and the highest is $2.94 billion. DaVita also reported sales of $2.91 billion during the same quarter last year. The firm is []

Analysts predict that DaVita Inc. (NYSE:DVA) will announce earnings per share (EPS) of $1.80 for the current quarter, according to Zacks. Four analysts have made estimates for DaVitas earnings, with estimates ranging from $1.66 to $1.91. DaVita posted earnings per share of $1.67 in the same quarter last year, which would indicate a positive year-over-year []

Some big stocks are poised to end the year as losers, but the value category's extended stretch of underperformance may be coming to a close.

Park Avenue Securities LLC increased its stake in shares of DaVita Inc. (NYSE:DVA) by 3.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,813 shares of the companys stock after purchasing an additional 160 shares during the quarter. Park []

New Jersey, United States,- Verified Market Research has recently published a research report titled, Dialysis Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to formulate this